Maintenance treatment of combination with bevacizumab vs single agent for advanced non-squamous non-small cell lung cancer: A systematic review and meta-analysis

BACKGROUND: When the patients of advanced non-squamous non-small cell lung cancer (NSCLC) have achieved remission by induction therapy, it is controversial that combination with bevacizumab is used as maintenance therapy. Pemetrexed is a classic drug for maintenance therapy, is bevacizumab the super...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Ying, Hong, Liang, Xu, Xiaocheng, Xu, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341328/
https://www.ncbi.nlm.nih.gov/pubmed/34397863
http://dx.doi.org/10.1097/MD.0000000000026862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341328/
https://www.ncbi.nlm.nih.gov/pubmed/34397863
http://dx.doi.org/10.1097/MD.0000000000026862

Ejemplares similares